Valuation check: RENX's profit margin is -169.19%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for RENX is -169.19% as of June 2026. That compares with -716.32% in the prior-year period — up 76.4% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside RenX Enterprises's historical trend and sector peers before judging valuation or financial health.
Over the past year, RENX's profit margin moved from -716.32% to -169.19% — a 76.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RenX Enterprises's valuation or profitability profile.
Against Healthcare companies, RENX currently prints -169.19% for profit margin, while the sector average sits near 17.63%. That is roughly 1059.7% below the sector mean. Large gaps often invite a closer look at RenX Enterprises's growth, margins, and balance sheet.
Profit Margin shows how effectively RenX Enterprises converts resources into returns. At -169.19%, RENX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -716.32% in the prior-year period — up 76.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting RENX's profit margin (-169.19%), review year-over-year change from -716.32%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.